Pharma Deals Review, Vol 2009, No 5 (2009)

Font Size:  Small  Medium  Large

CombinatoRx's Oncology Collaboration with Novartis

Taskin Ahmed

Abstract


CombinatoRx Inc. announced an oncology collaboration with Novartis AG, the Swiss drug giant, that will yield CombinatoRx an up-front payment of US$4 M.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.